These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10348214

  • 1. Erythroid accelerating activity of rat serum in early stage of drug induced hemolysis.
    Umenai T, Yokoyama M.
    Tohoku J Exp Med; 1998 Nov; 186(3):181-91. PubMed ID: 10348214
    [Abstract] [Full Text] [Related]

  • 2. Erythroid accelerating factor detected in serum from rats with drug induced hemolysis.
    Kasai M, Yokoyama M, Toki T, Maruyama H, Satoh K, Itoh E.
    Tohoku J Exp Med; 1998 Dec; 186(4):279-89. PubMed ID: 10328160
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L, Frazier JG, Sytkowski AJ.
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [Abstract] [Full Text] [Related]

  • 5. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
    Piron M, Loo M, Gothot A, Tassin F, Fillet G, Beguin Y.
    Blood; 2001 Jan 15; 97(2):442-8. PubMed ID: 11154221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY, Huang JY.
    Nephron; 1998 Jan 15; 79(2):142-7. PubMed ID: 9647492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X, Gao M, Chen Y, Liu J, Qi S, Ma J, Zhang Z, Xu Y.
    Blood Cells Mol Dis; 2016 May 15; 58():45-51. PubMed ID: 27067488
    [Abstract] [Full Text] [Related]

  • 15. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
    Menon MP, Karur V, Bogacheva O, Bogachev O, Cuetara B, Wojchowski DM.
    J Clin Invest; 2006 Mar 15; 116(3):683-94. PubMed ID: 16511603
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of regulation of erythropoiesis during hemolytic anemia.
    Zyuz'kov GN, Abramova EV, Dygai AM, Gol'dberg ED.
    Bull Exp Biol Med; 2004 Oct 15; 138(4):334-7. PubMed ID: 15665937
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
    Nakanishi T, Kimura T, Kuragano T.
    Contrib Nephrol; 2019 Oct 15; 198():124-134. PubMed ID: 30991414
    [Abstract] [Full Text] [Related]

  • 19. Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro.
    Steinlein P, Deiner E, Leutz A, Beug H.
    Growth Factors; 1994 Oct 15; 10(1):1-16. PubMed ID: 8179929
    [Abstract] [Full Text] [Related]

  • 20. Reduced erythroid cell and erythropoietin production in response to acute anemia in prion protein-deficient (Prnp-/-) mice.
    Zivny JH, Gelderman MP, Xu F, Piper J, Holada K, Simak J, Vostal JG.
    Blood Cells Mol Dis; 2008 Oct 15; 40(3):302-7. PubMed ID: 17964827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.